Integrated Diagnostics : Presentation for 1H2022 results
September 22, 2022 at 09:30 am EDT
Share
IDH Results Presentation
September 2022
Contents:
IDH At a Glance
1H 2022 Results Overview
Key Investment Highlights
Our Market
Our Business Model
Financial Position and Performance
Growth Strategies
Governance
Who We Are
Integrated Diagnostics Holding is a leading, fully-integrated provider of high-quality medical
diagnostic services with a footprint spanning Egypt, Jordan, Sudan and Nigeria
Our Services
Our Brands
Accreditations
Immunology Radiology Hematology
Endocrinology
Clinical
Molecular
Chemistry
Biology
Cytogenetics
Histopathology
Microbiology
+ 40 years
7 key brands
538
33.7 MN
21%
Hena Holdings
Track record
With strong awareness
Branch labs as at 30 June 2022
FY21 Tests
Ltd
+2,000
4
10.3 MN
EGP 5.0 BN
Shareholding 52%
Actis Idn B.V.
Structure
Free Float
Diagnostic tests
Country footprint (Egypt,
FY21 Patients
FY21 Net Sales
offered
Jordan, Sudan & Nigeria)
27%
INTEGRATED DIAGNOSTICS HOLDINGS
Our Geography
IDH currently operates the largest branch network amongst private providers in Egypt and boasts
an established presence in three key markets in the Middle East and Africa
Egypt
1979
488
#1
First began
Branches (49% in
Market Ranking1
(#1 in Corporate
operations
Cairo Region)
Insurance Sector)
81%
8.5 mn
29.7 mn
Share of
Patients served
Tests performed
consolidated net
in 2021
in 2021
sales in 1H 2022
Jordan
2011
21
#1
Acquisition of
Branches
Market Ranking1
Biolab
17%
1.6 mn
3.5 mn
Share of
Patients served
Tests performed
consolidated net
in 2021
in 2021
sales in 1H 2022
Market ranking amongst private players in each respective country.
4 INTEGRATED DIAGNOSTICS HOLDINGS
Nigeria
2018
12
1.8%
Acquisition of
Share of
Branches
consolidated net
Echo Lab
sales in 1H 2022
153k
281k
Patients served
Tests performed
in 2021
in 2021
Sudan
2011
17
#1
First began
Branches
Market Ranking1
operations
0.6%
70k
182k
Share of
Patients served
Tests performed
consolidated net
in 2021
in 2021
sales in 1H 2022
Our Patients
IDH serves two principal types of patients: contract and walk-in
Around 70% of total revenue generated across the two segments is paid in cash
Contract Patients
IDH's contract clients include institutions who enter into one-year renewable contracts at agreed rates per-test and on a per-client basis. Around 40% of the revenue generated by the segment is paid in cash. IDH's corporate clients roster currently features institutions such as:
Unions
Syndicates
Private and public insurance companies
Banks and corporations
Public institutions
Walk-In Patients
IDH's walk-in clients, also referred to as "self-payers", pay out of pocket for diagnostic tests and other services.
Contribution to IDH Net Sales (1H 2022)
42% EGP
1,891
mn 58%
Patient Split by Segment (1H 2022)
33%
4.5 mn
patients
67%
Contract Revenues
Walk-in Revenues
Contract Patients
Walk-in Patients
INTEGRATED DIAGNOSTICS HOLDINGS
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
IDH - Integrated Diagnostics Holdings plc published this content on 20 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 September 2022 13:29:07 UTC.
Integrated Diagnostics Holdings PLC is a consumer healthcare company. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology and others. The Companyâs brands include Al Borg Scan, Al Mokhtabar, Ultralab, Biolab, Echo-Lab and others. It operates in approximately 552 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography-computed tomography (PET-CT), electromyography (EMG), electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities.
INTEGRATED DIAGNOSTICS HOLDINGS PLC 
